uncontrolled and prolonged course of asthma leads to a decrease in the glomerular filtration rate (GFR) which develops as a result of the depletion of the compensatory capacity of the kidneys to maintain effective filtration pressure due to persistent renal blood flow disorders. The deterioration of the conditions of glomerular filtration in the future can cause significant renal dysfunction and worsening of the prognosis in patients with severe asthma in combination with type 2 diabetes and obesity.
The aim of the study is to analyze metabolic disturbances and velocity of glomerular filtration rate in patients with asthma in combination with type 2 diabetes mellitus.
Materials and methods
The work was performed on the basis of the clinic communal health care institution "Emergency Medicine Center", which is the clinical base of the Department of Propedeutic of internal medicine №2 and the nursing care of the Kharkiv National Medical University and on the clinical base of the communal health care institution of "Kharkiv city hospital №13". 105 patients with asthma in combination with DM2T (main group) and 62 patients with isolated asthma (comparison group) were examined. All investigated patients suffered from uncontrolled moderate asthma. Target indicators for the treatment of patients with diabetes were given by EASD 2013. To control the carbohydrate metabolism in the blood serum, glucose levels were determined on the basis of by the enzymatic colorimetric method with deproteinization (Olvex Diagnosticum, Russia) and glyсated hemoglobin (HbA1c) by means of biochemical techniques taking into account the reaction with thiobarbituric acid. The concentration of insulin in the blood serum was defined using "Insulin ELISA" ("DRG Diagnostics", Germany) kits with the help of a in solid-phase radioassay. Insulin resistance was determined using the model HOMA-IR = insulin concentration (μd / ml) × glucose (mmol / L) / 22.5. The velocity of glomerular filtration rate was calculated according to the nomogram for the calculation of GFR based on the level of creatinine in the blood serum, with the regard of to sex, age and race using the formula CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration 
Results of research and discussion
When studying the parameters of external respiration (ER), in all the patients the volume and speed indices were reduced. FEV 1 in the patients of the main group was 50.75 [44.75; 59.00]%, in the patients of the comparison group -56.00 [44.50; 69,10]% (p > 0,05); which ,compared to the control group, had a significant difference (p < 0,001) in comparison with control group. When comparing the speed indicators at the level of FEF 25 , FEF 50 , and FEF 75 , there was a significant difference in the patients between the groups (p < 0.05). The analysis of GFR revealed a decrease of this indicator parameter in two groups of the patients in relation to the compared with control group (p < 0.05). In the patients of the main group it was 53.40 [49,73; 60.79] ml / min / 1.73 m 2 , that was 2.2 times lower than in the control group and 1.2 times lower fewer than in the comparison group (p < 0.05). Significant differences testify to a kidney function abnormality in the patients under study; namely, their perfusion properties. Hypoxemia, present in a moderate asthma, may be mediated by renal dysfunction [2, 9] .
To confirm this fact, we obtained positive correlation interactions of different strength in the investigated groups of the patients between the speed indicators and GFR: FEV 1 and GFR (R = 0.41; p < 0.05; R = 0.39; p < 0.05) respectively, and between FEF75 % and GFR (R = 0.55; p < 0.05; R = 0 , 37; p <0.05) respectively. The decrease in GFR in the patients of the main group was accompanied by microalbuminuria, which amounts 72.00 [30.00; 130.00] mg / l (p < 0.001). In the comparison group microalbuminuria was absent.
In the distribution of patients, depending on the violation of FEV 1 , 3 subgroups were formed (FEV 1 < 50 %, 50 % ≤ FEV 1 ≤ 60 %, FEV 1 > 60 %) and 3 subgroups with depending on the violation of GFR (GFR < 60, ml / min / 1.73 m 2 , 60 ≤ GFR < 90, ml / min / 1.73 m 2 and GFR ≥ 90, ml / min / 1.73 m 2 ). With the progression of bronchial obstruction in the patients of the main group, the probable differences in the HOMA-IR index, depending on the syndrome of bronchial obstruction, were detected. HOMA-IR was maximally raised in the patients with FEV1 < 50 % in both groups (p < 0.001), which coincided with atherogenic disorders. According to the results of our research, atherogenic dyslipidemia was discovered in all the examined patients, mostly due to hypertriglyceridemia. When analysing lipid metabolism indices in patients with asthma + DM2T with the syndrome of bronchial obstruction, a high level of significance of TCH, TG and LDL CH was observed between the subgroups FEV 1 ≤ 50 % and 50 % ≤ FEV 1 ≤ 60 % (p < 0.05). In the subgroup FEV 1 < 50 %, the rates were the highest, indicating the development of hypoxia, which contributes to the development of atherogenic changes in patients with asthma with and type 2 diabetes. Sizable differences were found in the patients of the main group with 50 % ≤ FEV 1 ≤ 60 % (p < 0.05) compared to the control group according to the parameters of THC, TG and LDL. In the correlation analysis between FEV 1 < 50 % and the level of lipids -THC, LDL, and TG -in the patients of the main group the inverse association feedback was revealed (R = -0.31; p < 0.05; R = -0.42; p < 0 , 05, R = -0,54; p < 0,05) and TG in the patients of the comparison group (R = -0,39; p < 0,05).
As the bronchial obstruction syndrome progressed, an increase in the level of insulin and the HOMA-IR index was observed. In the patients with FEV1 < 50 %, HOMA-IR was lower than in the patients with FEV 1 > 60% (p < 0.001).
Conclusions

1.
Comorbidity of bronchial asthma with type 2 diabetes is accompanied by a cascade of metabolic disorders, which are manifested as probable changes in carbohydrate and fat metabolism indices. The reverse correlation changes were found in the patients of the main group between FEV 1 and BMI (R = -0.55 p <0.05;), between HDL and insulin (R = -0.36, p < 0.05), the index HOMA-IR and LDL (R = -0.37). 
